ZGEN Insider Trading Activity and SEC Form 4 Filings
ZGEN insider trading summary
No open-market insider purchases or sales of Zymogenetics Inc (ZGEN) have been reported on SEC Form 4 in the past 12 months.
Latest ZGEN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 8, 2010 | Nordisk A S Novo | Insider | Sell | $215.9M (22,143,320 @ $9.75) |
| Sep 8, 2010 | James A Johnson | Executive VP and CFO | Sell | $195K (20,000 @ $9.75) |
| Jul 30, 2010 | Darren R Hamby | Sr. VP, HR & Corp Svcs | Sell | $79K (20,000 @ $3.96) |
| Feb 24, 2010 | Eleanor Ramos | Sr. VP, Chief Medical Officer | Sell | $4K (662 @ $5.66) |
| Feb 24, 2010 | Dennis M. Miller | Sr VP, Resrch & Preclin Devl | Sell | $4K (662 @ $5.66) |
| Jan 7, 2010 | Nordisk A S Novo | 10% Owner | Buy | $7.5M (1,250,000 @ $6.00) |
| Dec 7, 2009 | James A Johnson | Executive VP and CFO | Sell | $70K (10,000 @ $7.00) |
| Aug 31, 2009 | James A Johnson | Executive VP and CFO | Sell | $60K (10,000 @ $6.00) |
| Mar 7, 2008 | Warburg Pincus & Co | 10% Owner | Buy | $14K (1,600 @ $8.70) |
| Mar 7, 2008 | Warburg Pincus Partners LLC | 10% Owner | Buy | $14K (1,600 @ $8.70) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.